Research Diagnosis Related Groups (DRG) level mortality quality outcomes for Stanford Healthcare located at 300 Pasteur Dr, Stanford, CA, 94305 & includes data from NPIs 1265581086, 1871543215
Dexur analyzed Q1 2019 (January to March 2019) Medicare claims data to benchmark mortality rates for Stanford Healthcare compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 2,666 | 2,564 | ||||||||||||||||||||||
Surgical | 1,285 | 1,259 | ||||||||||||||||||||||
Non Surgical | 1,381 | 1,305 | ||||||||||||||||||||||
Cardiovascular | 497 | 477 | ||||||||||||||||||||||
General Surgery | 416 | 401 | ||||||||||||||||||||||
Orthopedics | 361 | 357 | ||||||||||||||||||||||
General Medicine | 314 | 289 | ||||||||||||||||||||||
Gastroenterology & Endocrinology | 178 | 174 | ||||||||||||||||||||||
Pulmonology | 172 | 164 | ||||||||||||||||||||||
Urology | 160 | 157 | ||||||||||||||||||||||
Oncology & Hematology | 158 | 149 | ||||||||||||||||||||||
Neurology | 142 | 134 | ||||||||||||||||||||||
Spine | 112 | 111 | ||||||||||||||||||||||
Colorectal | 52 | 51 | ||||||||||||||||||||||
Psychiatry & Mental Disorders | 45 | 43 | ||||||||||||||||||||||
Obesity, Bariatric, Stomach & Duodenal | 30 | 29 | ||||||||||||||||||||||
Obstetrics & Gynecology | 22 | 21 |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Heart Failure And Shock | ||||||||||||||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Endovascular Procedures | ||||||||||||||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Circulatory System Diagnoses | ||||||||||||||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Acute Myocardial Infarction | ||||||||||||||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Coronary Bypass | ||||||||||||||||||||||||
Other Vascular Procedures | ||||||||||||||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||||||||||||||
Peripheral Vascular Disorders | ||||||||||||||||||||||||
Aortic And Heart Assist Procedures | ||||||||||||||||||||||||
DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Cardiothoracic Procedures | ||||||||||||||||||||||||
Percutaneous Intracardiac Procedures |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Craniotomy And Endovascular Intracranial Procedures | ||||||||||||||||||||||||
DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 026: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Chest Procedures | ||||||||||||||||||||||||
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Pancreas, Liver And Shunt Procedures | ||||||||||||||||||||||||
DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||||||||||||||
Other O.R. Procedures For Injuries | ||||||||||||||||||||||||
DRG 907: OTHER O.R. PROCEDURES FOR INJURIES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Tracheostomy For Face, Mouth And Neck Diagnoses Or Laryngectomy | ||||||||||||||||||||||||
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||||||||||||||
DRG 464: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Craniotomy With Major Device Implant Or Acute Complex Cns Pdx | ||||||||||||||||||||||||
DRG 023: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR CHEMOTHERAPY IMPLANT | ||||||||||||||||||||||||
Hernia Procedures | ||||||||||||||||||||||||
Extracranial Procedures | ||||||||||||||||||||||||
Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major Procedure | ||||||||||||||||||||||||
Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||||||||||||||
DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 480: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||||||||||||||
DRG 493: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||||||||||||||
Medical Back Problems |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
Postoperative And Post-Traumatic Infections | ||||||||||||||||||||||||
DRG 862: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Complications Of Treatment | ||||||||||||||||||||||||
Signs And Symptoms | ||||||||||||||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cellulitis |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
G.I.Hemorrhage | ||||||||||||||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Disorders Of Biliary Tract | ||||||||||||||||||||||||
Other Digestive System Diagnoses | ||||||||||||||||||||||||
G.I. Obstruction | ||||||||||||||||||||||||
Diabetes | ||||||||||||||||||||||||
Disorders Of Pancreas Except Malignancy | ||||||||||||||||||||||||
Endocrine Disorders |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Respiratory System Diagnoses | ||||||||||||||||||||||||
DRG 205: OTHER RESPIRATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Respiratory Infections And Inflammations | ||||||||||||||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||||||||||||||
Major Chest Trauma | ||||||||||||||||||||||||
Chronic Obstructive Pulmonary Disease |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Kidney And Ureter Procedures | ||||||||||||||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Bladder Procedures | ||||||||||||||||||||||||
DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Kidney Transplant | ||||||||||||||||||||||||
DRG 652: KIDNEY TRANSPLANT |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||||||||||||||
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Digestive Malignancy | ||||||||||||||||||||||||
DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Lymphoma And Non-Acute Leukemia | ||||||||||||||||||||||||
Respiratory Neoplasms | ||||||||||||||||||||||||
DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Seizures | ||||||||||||||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Degenerative Nervous System Disorders | ||||||||||||||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Disorders Of Nervous System | ||||||||||||||||||||||||
Cranial And Peripheral Nerve Disorders | ||||||||||||||||||||||||
DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Traumatic Stupor And Coma, Coma > 1 Hour |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Combined Anterior/Posterior Spinal Fusion | ||||||||||||||||||||||||
DRG 454: COMBINED ANTERIOR/POSTERIOR SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Spinal Fusion Except Cervical | ||||||||||||||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cervical Spinal Fusion | ||||||||||||||||||||||||
Spinal Fusion Except Cervical With Spinal Curvature / Malignancy / Infection Or Extensive Fusions | ||||||||||||||||||||||||
DRG 457: SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE OR MALIGNANCY OR INFECTION OR EXTENSIVE FUSIONS WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||||||||||||||
DRG 885: PSYCHOSES |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jan 2019 to Mar 2019) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uterine And Adnexal Procedures For Malignancy |